Study: Restoring Muscle after Sepsis in Mice
Sepsis is an inflammatory response by the entire body to severe infection. Surviving patients can suffer from severe impairment, particularly at neurological and muscular level, which can be highly debilitating and can prevent survivors from leading a normal active life in the long term.
For this study, Prof. Fabrice Chrétien, from the Institut Pasteur, and colleagues investigated the consequences of sepsis on muscle stem cells — known as satellite cells — which develop into muscles, particularly in the limbs. They observed a significant decrease in the mitochondrial mass of these stem cells in mouse models. Mitochondria are organelles that produce the energy-rich ATP molecules which are required for all chemical reactions. Following sepsis, the few remaining mitochondria provide satellite cells with just enough energy for their basic survival, but not enough for dividing and differentiating into muscle cells when required for muscle growth, repair and maintenance. This damage prevents the organism from fully restoring muscle function, hence the persistent muscle impairment observed in patients, according to the researchers.
This research led the investigators to explore the possibility of using mesenchymal stem cell transplantation as a potential avenue for therapy. Mesenchymal stem cells can be easily cultured in the laboratory and are known for their immunomodulatory properties, which makes them an excellent option for cell therapy transplants that aim to repair degenerative or traumatic lesions. Using a mouse model, Prof. Chrétien and his team demonstrated that an intramuscular mesenchymal stem cell transplant carried out after septic shock resulted in a drop in the level of overall inflammation and related symptoms: fever, atony (loss of muscle tone), circulation of cytokines, inflammatory molecules, etc.
A histological analysis conducted after the transplant revealed that the mesenchymal stem cells provided support for the damaged satellite cells without actually replacing them. The mesenchymal stem cells were then eliminated by the organism, with the transplant having successfully repaired the mitochondrial damage and fully restored the metabolic and division capability of the satellite cells.
Encouraged by the results, Prof. Chrétien's team is preparing to continue their investigation in humans. The first stage of their research, which should confirm whether the same tissue damage is observed in human patients, is due to begin shortly.
Source and image credit: Institut Pasteur
Published on : Mon, 21 Dec 2015
The HAMILTON-G5 is Hamilton Medical’s most modular high-end mechanical ventilator. A wide range of standard features and options allows you to tailor the HAMILTON-G5 to your needs. · Automated control of the patient’s ventilation a
Intended to establish emergency airway access when endotracheal intubation cannot be performed. Features and benefits Supplied in a slip-peel pouch for easy transportation. The dilators are preinserted into the airway catheters for...
Right when it matters. Right where it counts. Simplify assessments and deliver effective care with Venue Go. Featuring a uniquely adaptable design that goes from cart to table to wall, Venue Go supports Point of Care medicine across...
Developed for long-term lung support - approved for 29 days of use Elementary features: • Proven reliability and safety • Certified for 29 days application period • Matching pump sizes for ¼ "" or 3/8"" tubing • x.ellence, a multi-layer coating...
Intended for emergency transtracheal catheter ventilation when conventional ventilation by mask or endotracheal tube cannot be performed. Features and benefits The set provides clinicians with a compact solution for quickly establishing...